Neurology · Episodic Ataxia Type 9

Getting the Right Diagnosis: Genetic Testing and Mimics

At a Glance

Diagnosing Episodic Ataxia Type 9 may require more than a standard exome test: doctors may need targeted testing for FGF14 or SCN2A changes, including repeat expansions, while checking for mimics such as vestibular migraine, vitamin deficiency, autoimmune disease, and vascular events.

Getting a diagnosis for Episodic Ataxia Type 9 (EA9) is often a complex journey because the “glitch” in the DNA can hide in places where standard tests don’t look. To understand your diagnosis, you first need to know that your doctor is essentially looking for specific genetic changes, such as variants in the FGF14 or SCN2A genes ^[1]^[2].

Why Standard Tests Often Miss the Answer

Most people start with a test called Whole Exome Sequencing (WES) or a standard “Ataxia Panel.” These tests are excellent at reading the “sentences” of your DNA (called exons) to find spelling errors, known as sequence variants ^[2].

However, a closely related condition called SCA27B—which also causes episodic ataxia—is caused by a GAA repeat expansion ^[2]. This expansion is located in an intron, a deep part of the gene that most standard tests skip over. Imagine a book where the spelling is perfect, but one page has been copied and pasted 300 times in a row; a standard spell-checker (WES) wouldn’t notice the extra pages because it only looks at the words themselves ^[3]^[4].

To find these “extra pages,” doctors must use specialized tools:

Repeat-Primed PCR: A targeted test that specifically counts the number of times a DNA segment repeats ^[5].
Long-Read Sequencing: A newer technology that can read through long, repetitive sections of DNA that confuse older machines ^[6].

Ruling Out the “Look-Alikes”

Because the symptoms of EA9—like dizziness and stumbling—are common, doctors must rule out “secondary” causes that are not genetic. Research shows these mimics are actually more common than the genetic forms of episodic ataxia ^[7].

Common mimics include:

Vestibular Migraine: This is a leading mimic where migraine activity causes dizziness and balance issues, often without a headache ^[8].
Nutritional Deficiencies: Low levels of certain vitamins (like B1 or E) can cause “ataxia-like” symptoms ^[9].
Inflammatory/Autoimmune Issues: Conditions where the immune system mistakenly attacks the cerebellum ^[7]^[10].
Vascular Causes: Small “mini-strokes” (TIAs) can cause brief episodes of stumbling ^[7].

To rule these out, your medical team may use Brain MRI to look for physical changes in the cerebellum, or Vestibular Testing (like the “head impulse test”) to see if the balance problem is in your inner ear rather than your brain ^[11]^[12]. Note that a normal MRI does not exclude episodic ataxia or every dangerous cause, and appropriate medication or toxin review is also necessary.

Genetic Test Completeness Checklist

If you have a genetic report in hand, it should contain these specific pieces of information to be considered “complete.” If any are missing, your doctor may need to call the lab for clarification.

The Specific Gene: It should clearly state FGF14 (for EA9/SCA27B) or SCN2A (another cause of EA9) ^[1]^[13].
The Variant Type: Does it say Sequence Variant (a spelling change) or Repeat Expansion (extra copies of DNA)? This changes your diagnosis from EA9 to SCA27B ^[2].
Repeat Count (for expansions): It should list the number of GAA repeats. For SCA27B, a count of 250 or more is often associated with pathogenicity, while counts between 200–249 may have reduced penetrance depending on the laboratory method and repeat interruptions ^[14]^[3]. Repeat count alone cannot definitively predict severity.
Classification: The lab should label the finding as Pathogenic, Likely Pathogenic, or a Variant of Uncertain Significance (VUS) ^[15]. A VUS must not be used to guide predictive testing or treatment.
The Lab Method: It should specify if they used PCR, Exome Sequencing, or Long-Read Sequencing ^[5]^[16].

If your report only says “Episodic Ataxia Type 9” without these genetic details, it may be a clinical diagnosis based on symptoms rather than a confirmed genetic one. A clinical diagnosis can remain valid if testing is unavailable, but confirming the genetic “why” helps tailor specific treatment and inheritance counseling ^[17].

Common questions in this guide

Can a whole exome test miss the genetic cause of episodic ataxia?

Yes. Whole exome sequencing primarily reads coding parts of genes and can miss repeat expansions in noncoding regions, such as the FGF14 GAA expansion associated with SCA27B. Targeted repeat-primed PCR or long-read sequencing may be needed when clinical suspicion remains.

What genetic changes are tested for in Episodic Ataxia Type 9?

Testing may look for sequence variants in the FGF14 or SCN2A genes, depending on the clinical situation and laboratory panel. An FGF14 GAA repeat expansion is associated with SCA27B, a related condition that can also cause episodic ataxia.

What does the repeat count mean on an FGF14 test?

For SCA27B, 250 or more GAA repeats is often associated with a disease-causing result, while 200 to 249 repeats may have reduced penetrance depending on the laboratory method and repeat interruptions. The repeat count alone cannot predict how severe symptoms will be.

What other conditions can look like episodic ataxia?

Vestibular migraine, vitamin B1 or E deficiency, autoimmune inflammation affecting the cerebellum, vascular events such as transient ischemic attacks, and medication or toxin effects can cause similar symptoms. Doctors may use brain MRI, vestibular testing, clinical history, and medication review to evaluate these possibilities.

Does a normal brain MRI rule out episodic ataxia?

No. A normal MRI does not exclude episodic ataxia or every potentially dangerous cause of balance symptoms. Genetic testing, vestibular assessment, and a careful clinical evaluation may still be needed.

What should be included in a complete genetic test report?

A report should identify the gene, variant type, repeat number when relevant, laboratory classification, and testing method. A variant of uncertain significance has an unclear meaning and should not be used by itself to guide predictive testing or treatment.

Get notified when new evidence is published on episodic ataxia, type 9.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References (17)

1
FGF14-related episodic ataxia: delineating the phenotype of Episodic Ataxia type 9.
Piarroux J, Riant F, Humbertclaude V, et al.
Annals of clinical and translational neurology 2020; (7(4)):565-572 doi:10.1002/acn3.51005.
PMID: 32162847
2
Pearls & Oy-sters: SCA27B as an Elusive Genetic Cause of Episodic Neurologic Symptoms in Later Adulthood.
Yomtoob J, Morse L, Keller Sarmiento IJ, et al.
Neurology 2026; (106(6)):e214754 doi:10.1212/WNL.0000000000214754.
PMID: 41698164
3
Characteristics of a Cohort of Individuals With SCA27B Associated With Repeat Expansions in FGF14.
Anderson SC, Patel SG, Rodrigues M, et al.
Neurology. Genetics 2026; (12(5)):e200424 doi:10.1212/NXG.0000000000200424.
PMID: 42699715
4
Spinocerebellar Ataxia Type 27B can be Suspected Based on Clinical Phenotype: The Massachusetts General Hospital Ataxia Center Experience.
Rettenmaier LA, Chen JYH, MacMore J, et al.
Cerebellum (London, England) 2025; (24(5)):133 doi:10.1007/s12311-025-01882-3.
PMID: 40679574
5
Optimized testing strategy for the diagnosis of GAA-FGF14 ataxia/spinocerebellar ataxia 27B.
Bonnet C, Pellerin D, Roth V, et al.
Scientific reports 2023; (13(1)):9737 doi:10.1038/s41598-023-36654-8.
PMID: 37322040
6
FGF14 repeat length and mosaic interruptions: modifiers of spinocerebellar ataxia 27B?
Laß J, Thomsen M, Borsche M, et al.
Brain : a journal of neurology 2025; (148(11)):4072-4083 doi:10.1093/brain/awaf183.
PMID: 40379261
7
Episodic Ataxias: Primary and Secondary Etiologies, Treatment, and Classification Approaches.
Hassan A
Tremor and other hyperkinetic movements (New York, N.Y.) 2023; (13()):9 doi:10.5334/tohm.747.
PMID: 37008993
8
Update on diagnosis and differential diagnosis of vestibular migraine.
Shen Y, Qi X
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2022; (43(3)):1659-1666 doi:10.1007/s10072-022-05872-9.
PMID: 35015204
9
Clinicopathologic Correlates: Progressive Downbeat Nystagmus in Spinocerebellar Ataxia Type 27B.
Hale DE, Mu W, Gold DR
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2026; (46(1)):113-116 doi:10.1097/WNO.0000000000002452.
PMID: 41700956
10
Epilepsy and episodic ataxia type 2: family study and review of the literature.
Verriello L, Pauletto G, Nilo A, et al.
Journal of neurology 2021; (268(11)):4296-4302 doi:10.1007/s00415-021-10555-0.
PMID: 33983550
11
Ocular Motor and Vestibular Profile in Spinocerebellar Ataxia Type 27B: Toward a Practical Bedside Diagnostic Framework.
Ariello LE, Gold DR, Mu W, et al.
Cerebellum (London, England) 2025; (24(5)):149 doi:10.1007/s12311-025-01906-y.
PMID: 40906330
12
Neuroimaging in cerebellar ataxia in childhood: A review.
Serrallach BL, Orman G, Boltshauser E, et al.
Journal of neuroimaging : official journal of the American Society of Neuroimaging 2022; (32(5)):825-851 doi:10.1111/jon.13017.
PMID: 35749078
13
Clinical and genetic spectrum of SCN2A-associated episodic ataxia.
Schwarz N, Bast T, Gaily E, et al.
European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2019; (23(3)):438-447 doi:10.1016/j.ejpn.2019.03.001.
PMID: 30928199
14
Clinical and Genetic Characteristics of SCA27B: A Global Systematic Review and Meta-Analysis.
Mustafa F, Agarwal A, Garg A, et al.
Cerebellum (London, England) 2026; (25(4)).
PMID: 42360552
15
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Richards S, Aziz N, Bale S, et al.
Genetics in medicine : official journal of the American College of Medical Genetics 2015; (17(5)):405-24 doi:10.1038/gim.2015.30.
PMID: 25741868
16
A journey through genetic movement disorders caused by non-coding repeat expansions.
da Hora RPC, Rossi M, Procaci VR, et al.
Parkinsonism & related disorders 2025; (138()):107967 doi:10.1016/j.parkreldis.2025.107967.
PMID: 40701895
17
Vertigo and dizziness syndromes in children and adolescents: Clinical presentation and diagnostic pathway.
Huppert D, Strobl R, Zwergal A, et al.
Developmental medicine and child neurology 2026; doi:10.1111/dmcn.70506.
PMID: 42745351

This page is for informational purposes only and does not constitute medical advice. A neurologist or genetics professional should interpret your genetic report and symptoms.